MedPath
NMPA Approval

Rifandine Capsules

国药准字H35021313

June 17, 2020

Drug Information

利福定胶囊

胶囊剂

0.15g

化学药品

June 17, 2020

Company Information

Applicant Company

Manufacturing Company

福建省泉州市洛江万安科技园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利福定胶囊 - NMPA 批准文号 | MedPath